FDA rejects proposals to inoculate more people by halving vaccine dose

Published



The Food and Drug Administration rejected proposals floated by other federal health officials for cutting COVID-19 vaccine doses in half to cover twice as many people will provide.

“We know that some of these discussions about changing the dosing schedule … are based on a belief that changing the dose or dosing schedule can help get more vaccine to the public faster,” FDA Commissioner Stephen Hahn said in a statement Monday evening. “However, making such changes that are not supported by adequate scientific evidence may ultimately be counterproductive to public health.”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.